Low pretherapy skeletal muscle mass index is associated with an increased risk of febrile neutropenia in patients with esophageal cancer receiving docetaxel + cisplatin + 5-fluorouracil (DCF) therapy

Katsuhiko Nara(University of Tokyo Hospital), Hiroshi Suzuki(University of Tokyo Hospital), Yasuyuki Seto(The University of Tokyo), Tappei Takada(University of Tokyo Hospital), Tetsuro Toriumi(Saitama Medical University), Koichi Yagi, Yasuyoshi Sato(The Cancer Institute Hospital), Koichiro Kawasaki(The University of Tokyo), Takehito Yamamoto(University of Tokyo Hospital)
Supportive Care in Cancer
February 1, 2023
Cited by 6


Related Papers